Nasdaq · Financials

Alignment Healthcare, Inc. (ALHC)

As-reported financials and recent SEC filings for Alignment Healthcare, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$3.95B

Net income

$-724,000

Net margin

-0.0%

Diluted EPS

$0.00

ROE

-0.4%

P/E (TTM)

231.9×

Market cap

$4.79B

Debt / equity

1.8×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$3.95B	$2.70B	$1.82B	$1.43B	$1.17B
Gross profit	—	—	—	—	—
Operating income	$14.8M	$-101.6M	$-127.8M	$-128.6M	$-178.1M
Net income	$-724,000	$-128.0M	$-148.0M	$-149.5M	$-195.3M
Diluted EPS	$0.00	$-0.67	$-0.79	$-0.83	$-1.14

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-06-26

1442026-06-26

42026-06-18

1442026-06-18

42026-06-15

42026-06-15

1442026-06-12

1442026-06-12

Go deeper on ALHC

Search Alignment Healthcare, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.